V114 and Acute Otitis Media (V114-032/PNEU-ERA)

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

7,000

Participants

Timeline

Start Date

September 12, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Acute Otitis Media (AOM)
Interventions
BIOLOGICAL

V114

IM injection

OTHER

Pediatric vaccines

Standard of care vaccines administered according to the local recommended schedule.

Trial Locations (13)

10220

Bhumibol Adulyadej Hospital ( Site 0013), Sai Mai

10330

Chulalongkorn University ( Site 0008), Bangkok

10400

Phramongkutklao Hospital ( Site 0003), Bangkok

Ramathibodi Hospital, Mahidol University ( Site 0009), Rajthevee

10700

Siriraj Hospital ( Site 0004), Bangkok

11000

Bamrasnaradura Infectious Disease Institute ( Site 0011), Nonthaburi

11120

Panyananthaphikkhu Chonprathan Medical Center ( Site 0014), Pak Kret

12120

Faculty of Medicine Thammasat Univ. ( Site 0007), Khong Luang

34000

Sappasit Prasong Hosptial-Pediatric ( Site 0016), Ubon Ratchathani

40002

Srinagarind Hospital ( Site 0002), Khon Kaen

50200

Maharaj Nakorn Chiang Mai Hospital ( Site 0001), Chiang Mai

57000

Chiang Rai Prachanuchro Hospital-Pediatrics ( Site 0015), Chiang Rai

90110

Prince of Songkla University Faculty of Medicine ( Site 0005), Hat Yai

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT04193215 - V114 and Acute Otitis Media (V114-032/PNEU-ERA) | Biotech Hunter | Biotech Hunter